↓ Skip to main content
What is this page? Embed badge

Abstract PD10-11: Keyriched-1- A prospective, multicenter, open label, neoadjuvant phase ii single arm study with pembrolizumab in combination with dual anti-HER2 blockade with trastuzumab and…

Overview of attention for article published in Cancer Research, February 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
6 Mendeley
Summary News Dimensions citations
So far, Altmetric has seen 1 news story.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.